期刊文献+

TFF3在浸润性乳癌组织中的表达及其意义 被引量:2

EXPRESSION OF TFF3 AND ITS CLINICAL SIGNIFICANCE IN INVASIVE BREAST CANCER
下载PDF
导出
摘要 目的探讨三叶因子3(TFF3)在浸润性乳癌组织中的表达及其与临床病理特征和预后关系。方法采用免疫组织化学PV-9005法,分别检测118例浸润性乳癌和30例正常乳腺组织中TFF3的表达,并对TFF3不同表达病人的临床病理特征及预后进行分析。结果 118例浸润性乳癌组织中TFF3蛋白的高表达率为44.1%(52/118),TFF3表达与病人的年龄、淋巴结是否转移及雌激素受体、孕激素受体、人表皮生长因子2蛋白的表达相关(χ2=4.11~5.84,P<0.05)。TFF3低表达病人的5年无进展生存期显著长于TFF3高表达者(χ2=5.92,P<0.05),5年的总生存期也显著延长(χ2=5.75,P<0.05)。单因素分析表明,肿瘤大小、淋巴结转移、TFF3蛋白表达、分期可以作为浸润性乳癌预后因素。多因素分析显示,肿瘤大小、淋巴结转移、TFF3蛋白表达是独立的预后因素。结论 TFF3的表达与浸润性乳癌病人的临床特征及预后有关,其高表达者预后较差。 Objective To investigate the expression of TFF3 in invasive breast cancer (IBC) and its correlation with clini- copathologic characteristics and prognosis. Methods Immunohistochemistry PV-9005 method was used to detect the expression of TFF3 in 118 cases of IBC and 30 cases of normal breast tissue. Patients with different TFF3 expressions were analyzd for their ciinicopathologic features and prognosis. Results In the 118 IBC patients, the expression of TFF3 was 44.1%(52/118), being correlated with patient's age, with or without lymph node metastasis, HER2, ER and PR expression (χ^2 --4. 11-5. 84,P/, 0.05). Patients with low expression of TFF3 had a longer 5 year-progression-free survival than that with high TFF3 expression (χ^2= 5.92 ,P〈0.05) so did as overall survival (χ^2 = 5.75, P〈0.05). Univariate analysis showed that the size of tumor, lymph node metastasis, TFF3 protein expression and stages could be factors contributing the prognosis; multivariate analysis indicated that the above factors were independent prognostic factors. Conclusion High expression of TFF3 is associated with clinical fea- tures and prognosis in IBC patients, for those with high expression of TFF3 will have a poor prognosis.
出处 《齐鲁医学杂志》 2012年第4期303-305,共3页 Medical Journal of Qilu
基金 山东省自然科学基金(Y2006C23)
关键词 三叶因子3 乳腺肿瘤 病理学 临床 预后 trefoil factor 3 breast neoplasms pathology, clinical prognosis
  • 相关文献

参考文献10

  • 1SUEMORI S, LYNCH-DEVANEV K, PODOLSKY D K. Identification and charcterization of rat intestinal trefoil factor: tissue- and cell sepecific member of the trefoil protein family [J]. ProcNatlAcad, 1991,88:11017-11021. 被引量:1
  • 2路艳艳,田字彬,魏良洲,孔心涓,赵清喜,李玉军,孙显路.TFF3在胃癌、癌前病变及胃腺瘤中的表达及其与血管生成的关系[J].世界华人消化杂志,2009,17(36):3688-3692. 被引量:12
  • 3DHAR D K, WANG T C, TABARA H, et al. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis[J]. Clin Cancer Res, 2005, 11:6472 -6478. 被引量:1
  • 4KHOURY T, CHADHA K, JAVLE M, et al. Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma [J]. Int J Gastrointest Cancer, 2005,35(3):171-177. 被引量:1
  • 5LEUNG W K, YU J, CHAN F K L, et al. Expression of tre- foil peptidcs (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues[J]. Pathol, 2002,197 : 582-588. 被引量:1
  • 6CHAN V Y, CHAN M W, LEUNG W K, et al. Intestional trefoil factor promotes invasion in non-tumorigenic Rat-2 fibro- blast cell [J]. Regu Pept, 2005,127:87-94. 被引量:1
  • 7YAMACHIKA T, WERTHER J L, BIDUAN C, et al. Intes- tinal trefoil factor: a marker of poor prognosis in gastric carci- noma [J]. ClinCancer Res, 2002,8:1092 -1099. 被引量:1
  • 8NAGARAJAN KANNAN, JIAN KANG, XIANGJUN KONG, et al. Trefoil factor 3 is oncogenic and mediates anti- estrogen resistance in human mammary carcinoma[J]. Neo- plasia, 2010,12: 1041-1053. 被引量:1
  • 9KARLSSON P, COLE B F, PRICE K N, et al. The role of the number of uninvolved lymph nodes in predicting iocora- gional recurrence in breast cancer[J]. Clin Oncol, 2007,25: 2019- 2026. 被引量:1
  • 10DUNNWALD L K, ROSSING M A, LI C I, et al. Hormone receptor status, tumor characteristics and prognosis: a pro- spective cohort of breast cancer patients[J]. Breast Cancer Res, 2007,9:6-13. 被引量:1

二级参考文献15

  • 1张秋宁,马力.三叶因子3在胃癌组织中的表达及与血管形成的关系[J].现代肿瘤医学,2005,13(1):42-44. 被引量:11
  • 2Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A 1991; 88:11017-11021. 被引量:1
  • 3Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 2001; 204:49-95. 被引量:1
  • 4Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 2002; 197:582-588. 被引量:1
  • 5Taupin D, Pedersen J, Familari M, Cook G, Yeomans N, Giraud AS. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 2001; 81:397-408. 被引量:1
  • 6Yamachika T, Werther JL, Bodian C, Babyatsky M, Tatematsu M, Yamamura Y, Chen A, Itzkowitz S. Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. Clin Cancer Res 2002; 8: 1092-1099. 被引量:1
  • 7Dhar DK, Wang TC, Tabara H, Tonomoto Y, Maruyama R, Tachibana M, Kubota H, Nagasue N. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res 2005; 11:6472-6478. 被引量:1
  • 8Chen YH, Lu Y, De Plaen IG, Wang LY, Tan XD. Transcription factor NF-kappaB signals anfianoikic function of trefoil factor 3 on intestinal epithelial cells. Biochem Biophys Res Commun 2000; 274: 576-582. 被引量:1
  • 9Rodrigues S, Nguyen QD, Faivre S, Bruyneel E, Thim L, Westley B, May F, Flatau G, Mareel M, Gespach C, Emami S. Activation of cellular invasion by trefoil peptides and src is mediated by cyclooxygenase- and thromboxane A2 receptordependent signaling pathways. FASEB J 2001; 15: 1517-1528. 被引量:1
  • 10Rodrigues S, Van Aken E, Van Bocxlaer S, Attoub S, Nguyen QD, Bruyneel E, Westley BR, May FE, Thim L, Mareel M, Gespach C, Emami S. Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J 2003; 17:7-16. 被引量:1

共引文献11

同被引文献23

  • 1Bansal N, Yendluri V, Wenham RM. The molecular biology of en- dometrial cancers and the implications for pathogenesis, classifica- tion and targeted therapies [ J ]. Cancer Control, 2009, 16 ( 1 ) : 8-13. 被引量:1
  • 2Cerezo L, Cardenes H, Michae 1H. Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implica- tions[J]. Clin Transl Oncol, 2006,8(4) :231-241. 被引量:1
  • 3Rinnert M, Hinz M, Buhtz P, et al. Synthesis and localization of trefoil factor family (TFFl) peptides in the human urinary tract and TFF2 excretion into the urine [J]. Cell Tissue Res, 2010,339 ( 3 ) : 639-647. 被引量:1
  • 4Zergeroglu S, Ozdemir HB, Ozel M, et al. The prognostic importance of proliferative activity and oestrogen receptor epression in stage I endometrial carcinomas [J]. J Obstet Gynaecol, 2006,26 (8) : 798-80l. 被引量:1
  • 5Chen CL, Hsieh FC, Lieblein JC, et al. Stat3 activation in human endometrial and cervical cancers [J]. Br J Cancer, 2007,96 ( 4 ) : 591-599. 被引量:1
  • 6Emami S, Le Floch N, Bruyneel E, et al. Induction of scattering and cellular invasion by trefoil peptides insrc-and RhoA -trans- formed kidney and colonic epithelial cells [J]. FASEBJ, 2001,15 (2) :351-36l. 被引量:1
  • 7Mhawech-Fauceglia P, Wang D, Wang D, et al. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade3 and grade 1 stage I endometrioid adenocarcinoma [J]. PLoS One, 2011 ,6(3) :eI8066. 被引量:1
  • 8Babyatsky M, Lin J, Yio X, et al. Trefoil factor-3 expression in human colon cancer liver metastasis [J ]. Clin Exp Metastasis, 2009,26(2) : 143-5l. 被引量:1
  • 9Gates EJ, Hirschfield L, Matthews RP, et al. Body mass index as a Prognostic factor in endometrioid adenocarcinoma of the endometrium[J]. J Nat! Med Assoc , 2006,98(11) :1814-1822. 被引量:1
  • 10Nan F, Lu Q, Zhou J, et al. Altered expression of DACHI and cyclin D1 in endometrial cancer [J ]. Cancer Bioi Ther, 2009, 8 (16) :1534-1539. 被引量:1

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部